PlainPharmaWatch

CMS Open Payments · Program Year 2024

Biohaven Pharmaceutical Holding Company Ltd.

Biohaven Pharmaceutical Holding Company Ltd. reported $1,993,393.87 across General Payments, Research, and Ownership to 0 physicians and teaching hospitals across 2,430 transactions.

See the rankings → How this is sourced
$2.0M
All-tracks total
2,430
Transactions
0
Recipients
−$13.4M
General Payments vs PY2022

Biohaven Pharmaceutical Holding Company Ltd. reported $1,993,393.87 across all CMS Open Payments tracks (General + Research + Ownership) to 0 physicians and teaching hospitals in Program Year 2024 - ranking #449 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total), averaging $0.00 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer biohaven-pharmaceutical-holding-company-ltd Biohaven Pharmaceutical Holding Company Ltd.

$2.0M · #449/1,925 · 0.0% industry · PY2024

  • TOT $2.0M
  • RANK #449
  • SHARE 0.0%
  • TXN 2,430
  • RCP 0
  • CAT 0
  • GEN n/a
  • ΔGEN −$13.4M
  • PY 2024

Volume peers

Nearest volume peer: Calliditas Therapeutics US Inc. ($2.0M)

Immunocore Limited$2.0MRoche Diagnostics Corporation$2.0MShape Memory Medical Inc.$2.0MCalliditas Therapeutics US I…$2.0MBiohaven Pharmaceutical Hold…$2.0M
All-tracks payment totals near Biohaven Pharmaceutical Holding Company Ltd. (CMS Open Payments PY2024)

Biohaven Pharmaceutical Holding Company Ltd. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2022 to PY2023

Biohaven Pharmaceutical Holding Company Ltd.'s CMS-reported General Payments decreased by $13.4M (−99.9%) from PY2022 to PY2023.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.PY2023: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.PY2024: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2022 vs PY2023

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2022$13.4MPY2023$9.3K
PY2022
$13,396,313.09
PY2023
$9,275.00

What the Data Shows for Biohaven Pharmaceutical Holding Company Ltd.

$1,993,393.87: that is what Biohaven Pharmaceutical Holding Company Ltd. reported in payments to 0 physicians and teaching hospitals during Program Year 2024, spread across 2,430 transactions ($820.33 per transaction, $0.00 per recipient). The company sits at rank #449 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 0-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). Payments are distributed across multiple categories without a dominant single type.

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Biohaven Pharmaceutical Holding Company Ltd..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Biohaven Pharmaceutical Holding Company Ltd.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.